Home » Topics » Conferences

Conferences
RSS

New trinem reported by SRI

Sep. 12, 1997

DuPont Merck presents dual MMP/TNF-alpha-converting enzyme inhibitor

Sep. 12, 1997

L-374087: a new thrombin inhibitor developed at Merck & Co.

Sep. 12, 1997

YM-60828: an orally active factor Xa inhibitor from Yamanouchi

Sep. 11, 1997

New atypical antipsychotic agent from HMR

Sep. 11, 1997

LG Chemical characterizes new thrombin inhibitor

Sep. 10, 1997

SAR reported by Parke-Davis for series of N-type Ca2+ antagonists

Sep. 10, 1997

Resveratrol found in edible peanuts

Sep. 9, 1997

Ethnic differences in codeine's efficacy/side effects

Sep. 9, 1997

Voglibose preclinical results described at Japanese congress

Sep. 8, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...